Its just glass fed wont be approved. It has never been sold in US. It might have an impact for future volume, but as ceo started, it has no impact to sm1 volume this year. Glass fed is sold in australia, the volume is too low compared to a2 volumes. It is only a marginal volume if anything.
Ann: SM1 Announcement - Munchkin U.S. FDA process on hold, page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SM1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.020(7.27%) |
Mkt cap ! $64.48M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.5¢ | 27.5¢ | $10.30K | 35.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 11690 | 2 |
View Market Depth
| Last trade - 13.53pm 31/07/2024 (20 minute delay) ? |
| SM1 (ASX) Chart |